| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
27.7 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
1.93 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-8.92 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
14.09 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
100000.0 |
nM |
10.1128/aac.00081-07 |
| Giardia |
Giardia |
Potency |
163.2 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
BJ |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
BT-549 |
IC50 |
123.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
BV-173 |
IC50 |
0.8 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
Activity |
0.44 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
0.85 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
1.9 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
7.6 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
13.0 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
24.9 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
30.8 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
32.1 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
41.3 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
46.2 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
48.0 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
61.5 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
61.6 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Activity |
73.2 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
IC50 |
0.5 |
nM |
10.1016/j.bmc.2011.07.022 |
| Homo sapiens |
CCRF-CEM |
IC50 |
3.0 |
nM |
10.1021/acs.jmedchem.1c00790 |
| Homo sapiens |
CCRF-CEM |
IC50 |
3.0 |
nM |
10.1021/jm00080a029 |
| Homo sapiens |
CCRF-CEM |
Inhibition |
9.54 |
% |
10.1021/jm901428k |
| Homo sapiens |
CCRF-CEM |
Inhibition |
44.77 |
% |
10.1021/jm901428k |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Deoxycytidine kinase |
Kcat |
0.37 |
/s |
10.1021/jm800134t |
| Homo sapiens |
Deoxycytidine kinase |
Kcat |
0.6 |
/s |
10.1021/jm800134t |
| Homo sapiens |
Deoxycytidine kinase |
Km |
5100.0 |
nM |
10.1021/jm800134t |
| Homo sapiens |
Deoxycytidine kinase |
Km |
78000.0 |
nM |
10.1021/jm800134t |
| Homo sapiens |
Deoxycytidine kinase |
Ratio |
0.0077 |
/s/microM |
10.1021/jm800134t |
| Homo sapiens |
Deoxycytidine kinase |
Ratio |
0.0726 |
/s/microM |
10.1021/jm800134t |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
651.3 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
1158.2 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HCT-116 |
IC50 |
100.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| Homo sapiens |
HCT-116 |
IC50 |
300.0 |
nM |
10.1016/j.ejmech.2017.02.002 |
| Homo sapiens |
HCT-116 |
IC50 |
9430.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
HeLa |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
HEp-2 |
IC50 |
30.0 |
nM |
10.1021/acs.jmedchem.1c00790 |
| Homo sapiens |
HEp-2 |
IC50 |
30.0 |
nM |
10.1021/jm00080a029 |
| Homo sapiens |
HepG2 |
IC50 |
40.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| Homo sapiens |
HepG2 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
14.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
3.92 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
HPAC |
IC50 |
9320.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
HT-29 |
IC50 |
9440.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Huh-7 |
IC50 |
400.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| Homo sapiens |
Huh-7 |
IC50 |
1800.0 |
nM |
10.1016/j.ejmech.2017.02.002 |
| Homo sapiens |
Huntingtin |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
366.3 |
nM |
None |
| Homo sapiens |
Jurkat |
IC50 |
660.0 |
nM |
None |
| Homo sapiens |
K562 |
IC50 |
170.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
K562 |
IC50 |
7690.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
K562 |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LNCaP |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Mahlavu |
IC50 |
100.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
IC50 |
2000.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| Homo sapiens |
MCF7 |
IC50 |
2000.0 |
nM |
10.1016/j.ejmech.2017.02.002 |
| Homo sapiens |
MCF7 |
IC50 |
2350.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
MCF7 |
IC50 |
45000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
13.0 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
21.7 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
5804.8 |
nM |
None |
| Homo sapiens |
PC-3 |
IC50 |
8280.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2017.11.022 |
| Homo sapiens |
Phosphodiesterase 2A |
Inhibition |
7.91 |
% |
10.1016/j.bmc.2017.11.022 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
28000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
970.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
50.1 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Raji |
IC50 |
9.0 |
nM |
10.1016/j.bmc.2011.07.022 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Relaxin receptor 1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Relaxin receptor 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-MEL-2 |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
SK-N-AS |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
SK-OV-3 |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
15.9 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Activity |
10.0 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
T47D |
IC50 |
700.0 |
nM |
10.1016/j.ejmech.2014.10.080 |
| Homo sapiens |
THP-1 |
Ratio IC50 |
1.0 |
None |
None |
| Homo sapiens |
THP-1 |
Ratio IC50 |
2.0 |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase YES |
Potency |
79258.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
7.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
183.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
206.0 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ZR-75-1 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
ED50 |
5e-06 |
M |
10.1021/jm00148a015 |
| Human respirovirus 3 |
Human respirovirus 3 |
ED50 |
0.0005 |
M |
10.1021/jm00148a015 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
16.3 |
% |
10.6019/CHEMBL4513141 |
| Measles morbillivirus |
Measles morbillivirus |
ED50 |
0.0005 |
M |
10.1021/jm00148a015 |
| Mus musculus |
CT26 |
IC50 |
131.0 |
nM |
10.1021/jm2005173 |
| Mus musculus |
EL4 |
IC50 |
848.0 |
nM |
10.1021/jm2005173 |
| Mus musculus |
L1210 |
IC50 |
70.0 |
nM |
10.1021/acs.jmedchem.1c00790 |
| Mus musculus |
L1210 |
IC50 |
70.0 |
nM |
10.1021/jm00080a029 |
| Mus musculus |
L1210 |
IC50 |
393.0 |
nM |
10.1021/jm2005173 |
| Mus musculus |
L1210 |
ID50 |
2.6e-08 |
M |
10.1021/jm00148a015 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
19952.6 |
nM |
None |
| Mus musculus |
P388 |
ID50 |
3.2e-08 |
M |
10.1021/jm00148a015 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
16.28 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
7320.0 |
nM |
10.1021/jm00007a014 |
| Rattus norvegicus |
Adenosine A2a receptor |
Ki |
20400.0 |
nM |
10.1021/jm00007a014 |
| Rattus norvegicus |
Adenosine A3 receptor |
Ki |
207000.0 |
nM |
10.1021/jm00007a014 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
C6 |
IC50 |
9070.0 |
nM |
10.1021/jm2005173 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
MAT-Ly-Lu |
IC50 |
nan |
None |
10.1021/jm2005173 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
Activity |
nan |
None |
10.1016/s0006-2952(00)00334-8 |
| Rattus norvegicus |
Solute carrier family 22 member 2 |
Activity |
nan |
None |
10.1016/s0006-2952(00)00334-8 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.07801 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.2792 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
6.87 |
% |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100000.0 |
nM |
10.1128/aac.00081-07 |
| Streptococcus pyogenes |
Streptococcus pyogenes |
MIC |
nan |
None |
10.1128/aac.00081-07 |
| Streptococcus sp. |
Streptococcus sp. |
MIC |
100000.0 |
nM |
10.1128/aac.00081-07 |
| Vaccinia virus |
Vaccinia virus |
ED50 |
5e-06 |
M |
10.1021/jm00148a015 |
| None |
ADMET |
CL |
14.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
F |
40.0 |
% |
10.1021/acs.jmedchem.1c00790 |
| None |
ADMET |
MRT |
9.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
No. of cells |
91.0 |
% |
10.1016/s0960-894x(98)00452-1 |
| None |
ADMET |
No. of cells |
91.2 |
% |
10.1016/s0960-894x(98)00452-1 |
| None |
ADMET |
No. of cells |
93.8 |
% |
10.1016/s0960-894x(98)00452-1 |
| None |
ADMET |
No. of cells |
94.7 |
% |
10.1016/s0960-894x(98)00452-1 |
| None |
ADMET |
T1/2 |
16.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Toxic level |
5e-06 |
M |
10.1021/jm00148a015 |
| None |
ADMET |
Vdss |
7.7 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
16.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
DILI positive/negative |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
8.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
16.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
16.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Molecular identity unknown |
Potency |
7079.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
AC50 |
9070.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Fu |
0.79 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
9.1 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
13.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
165.0 |
nM |
10.1021/jm2005173 |
| None |
NON-PROTEIN TARGET |
IC50 |
200.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| None |
NON-PROTEIN TARGET |
IC50 |
285.0 |
nM |
10.1021/jm2005173 |
| None |
NON-PROTEIN TARGET |
IC50 |
300.0 |
nM |
10.1016/j.ejmech.2014.10.080 |
| None |
NON-PROTEIN TARGET |
IC50 |
352.0 |
nM |
10.1021/jm2005173 |
| None |
NON-PROTEIN TARGET |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| None |
NON-PROTEIN TARGET |
IC50 |
1800.0 |
nM |
10.1016/j.ejmech.2014.10.080 |
| None |
NON-PROTEIN TARGET |
IC50 |
2300.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| None |
NON-PROTEIN TARGET |
IC50 |
4000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| None |
NON-PROTEIN TARGET |
IC50 |
6000.0 |
nM |
10.1016/j.bmc.2015.04.059 |
| None |
NON-PROTEIN TARGET |
IC50 |
10000.0 |
nM |
10.1021/jm2005173 |
| None |
NON-PROTEIN TARGET |
Potency |
3434.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
4324.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
27041.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
30611.4 |
nM |
None |
| None |
No relevant target |
LogP |
-0.1 |
None |
10.1016/j.ejmech.2009.12.043 |
| None |
Unchecked |
Ac50 |
4.467 |
uM |
None |
| None |
Unchecked |
Ac50 |
14.13 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
AC50 |
240.4 |
nM |
None |
| None |
Unchecked |
AC50 |
317.7 |
nM |
None |
| None |
Unchecked |
AC50 |
4466.8 |
nM |
None |
| None |
Unchecked |
AC50 |
14130.0 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
50870.0 |
nM |
None |
| None |
Unchecked |
EC50 |
2958.0 |
nM |
None |
| None |
Unchecked |
EC50 |
4800.0 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
400.0 |
nM |
10.1016/j.bmcl.2017.12.070 |
| None |
Unchecked |
IC50 |
3625.0 |
nM |
None |
| None |
Unchecked |
IC50 |
5060.0 |
nM |
None |
| None |
Unchecked |
IC50 |
18400.0 |
nM |
None |
| None |
Unchecked |
IC50 |
80000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
9.0 |
% |
10.1021/jm9006356 |
| None |
Unchecked |
Kcat |
0.41 |
/s |
10.1021/jm800134t |
| None |
Unchecked |
Kcat |
0.96 |
/s |
10.1021/jm800134t |
| None |
Unchecked |
Ki |
100000.0 |
nM |
10.1021/jm9006356 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Km |
10800.0 |
nM |
10.1021/jm800134t |
| None |
Unchecked |
Km |
54000.0 |
nM |
10.1021/jm800134t |
| None |
Unchecked |
Potency |
6.5 |
nM |
None |
| None |
Unchecked |
Potency |
316.2 |
nM |
None |
| None |
Unchecked |
Potency |
679.2 |
nM |
None |
| None |
Unchecked |
Potency |
959.5 |
nM |
None |
| None |
Unchecked |
Potency |
1076.5 |
nM |
None |
| None |
Unchecked |
Potency |
1778.3 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
7621.3 |
nM |
None |
| None |
Unchecked |
Potency |
8199.5 |
nM |
None |
| None |
Unchecked |
Potency |
9594.6 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
20596.2 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
48086.9 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0178 |
/s/microM |
10.1021/jm800134t |
| None |
Unchecked |
Ratio |
0.038 |
/s/microM |
10.1021/jm800134t |